Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (KCT0011392) titled 'Hemodynamic OPTIMIzation of Pacing in Cardiac Amyloidosis' on Dec. 30, 2025.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Cross-over, Blinding/Masking : Open, Allocation : RCT
Primary Sponsor: Samsung Medical Center
Condition:
Diseases of the circulatory system
Intervention:
Others(pacing strategy) : This study is a randomized clinical trial comparing a hemodynamics-guided optimized pacing strategy with a conventional pacing strategy in patients with cardiac amyloidosis undergoing permanent cardiac pacing. In the optimized pacing group, the lower rate limit of...